Senior insider sale
Chief Scientific Officer at MOONLAKE IMMUNOTHERAPEUTICS — senior position signals high conviction
$3.00M
202.91K shares
What this filing means
REICH KRISTIAN plans to sell 202.91K shares of MOONLAKE IMMUNOTHERAPEUTICS valued at approximately $3.00M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/8/2025ACC: 0001969223-25-001044
Officer· Chief Scientific Officer
Since Apr 2022
202.91K
Shares to sell
$3.00M
Approx. market value
202.91K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Exchange of Shares
Exchange
1/20/2025
111.95KExchange of Shares
Exchange
1/20/2025
48.98KExchange of shares
Exchange
10/3/2023
41.98KTotal acquired202.91K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/20/2025 | Exchange of Shares Exchange | 111.95K | — |
1/20/2025 | Exchange of Shares Exchange | 48.98K | — |
10/3/2023 | Exchange of shares Exchange | 41.98K | — |
| Total | 202.91K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
202.91K
Market value
$3.00M
12/8/2025
Total
Units
202.91K
Value
$3.00M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/8/2025 | 202.91K | $3.00M | Nasdaq | Planned |
| Total | 202.91K | $3.00M | ||